- BNF:
- Not listed
- Status:
- Amber
- Decision Date:
- September 2018
Comments
See Shared Care guideline for drugs used in the management of ADHD in children and adults
3rd line option for the treatment of attention- deficit hyperactivity disorder in children aged 5 years and over and young adults
Amber Drug Classifications
- 1: Requiring specialist assessment to enable patient selection and initiation of treatment
- 3: Requiring short or medium term specialist monitoring of toxicity
search again